Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × camrelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 37 Carcinoma, Non-Small-Cell Lung 26 Triple Negative Breast Neoplasms 21 Stomach Neoplasms 20 Nasopharyngeal Carcinoma 19 Esophageal Neoplasms 18 Esophageal Squamous Cell Carcinoma 16 Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Colorectal Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 8 Lung Neoplasms 8 Sarcoma 7 Recurrence 7 Neoplasm Metastasis 7 Melanoma 6 Liver Neoplasms 6 Hodgkin Disease 5 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Advanced Gastric Cancer 5 Small Cell Lung Carcinoma 4 Neoplasms 4 Locally Advanced Gastric Cancer 4 Solid Tumor 3 Rectal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Osteosarcoma 3 Nasopharyngeal Neoplasms 3

Interventions

pembrolizumab 3 enzalutamide 2 blinatumomab 2 abiraterone 2 Stents 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 AMG 757 2 soybean oil, phospholipid emulsion 1 durvalumab 1 dostarlimab 1 cemiplimab 1 camrelizumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Neoadjuvant Therapy 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Hydroxyurea 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05202314 2023-02-21

NACSOC-02

Beijing Chao Yang Hospital

Phase NA Recruiting

Gastrointestinal

Bites and Stings, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡